IDENTIFICATION AND QUANTIFICATION OF POTENTIAL IMPURITIES USING LC-PDA COUPLED WITH NEW QDa MASS DETECTOR IN A NEW SINGLE TABLET REGIMEN CONTAINING DOLUTEGRAVIR, EMTRICITABINE AND TENOFOVIR DISOPROXIL FUMARATE TABLETS USED IN HIV-1 PREVENTION. International Research Journal of Pharmacy, [S. l.], v. 10, n. 3, p. 91–104, 2019. Disponível em: https://irjponline.org/index.php/irjp/article/view/315. Acesso em: 31 oct. 2026.